Exelon (EXC +0.5%) edges higher after Wells Fargo upgrades shares to Outperform from Market Perform with a $57 price target, raised from $50, as the firm points to several factors including new supportive nuclear-related legislative initiatives, particularly in Illinois, where 60% of the nuclear capacity of the company’s ExGen subsidiary is located.